Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

The adult mammalian heart bears limited regenerative capacity, resulting in the irreversible loss of cardiomyocytes post-cardiac injury, and often culminating in end-stage heart failure. Cardiomyocyte ...

Millions of people around the world die from heart failure every year. In future, a laboratory-grown heart patch could help with severe cases of cardiovascular disease, say scientists behind a ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

According to the researchers, the data obtained can become the basis for the development of safe protocols for cardiac cell ...

UCLA scientists have identified a protein called glycoprotein nonmetastatic melanoma protein B (GPNMB) as a critical regulator in the heart’s healing process after a heart attack (myocardial ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are widely used around the world to study heart disease and test new drugs.

Injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function, showing possible clinical relevance “It is widely acknowledged ...

The virus moved through the bloodstream into the heart, where it delivered the cBIN1 gene into heart cells. For this heart failure model, heart failure generally leads to death within a few months.